CEO, Jens-Ole Bock will join panel: How CRISPR Revolutionises Genomic Medicine, at PMWC2020

14-01-2020

Development is moving fast in the genome editing field and new applications are launched every quarter but do we really understand the level of complexity in genome editing and how to address quality and safety?

PMWC2020 - Track 1, Day 3, Jan. 24, 3:30pm at the Santa Clara Convention Center.

How CRISPR Revolutionizes Genomic Medicine

"Over the past few years, CRISPR has revolutionized the life sciences. Engineered to generate targeted DNA breaks, various DNA changes can be introduced in living organisms which offer the opportunity to treat a plethora of inherited diseases. The ongoing expansions of the CRISPR toolbox supports new applications across various domains of research and medicine. This session intends to provide an informative summary of latest breakthroughs with a focus on recent achievements and potential utility at the clinical setting. The discussion will also include challenges and needs to fully appreciate the potential of this technology"

-------------------------------------------------------------------------------------------------------------------------------------------------------------

COBO Technologies is a fast-growing CRO specialised in services and products for quality control of genome editing applications in research and clinical fields. The company supports customers globally with detailed DNA mutation analysis and complexed proteome expression profiling of cells, plants or animals modified with genome editing tools such as CRISPR-Cas9, ZFNs, Meganucleases and TALENs.

Tags

HashtagHashtagCRISPRHashtagHashtagCRISPR MedicineHashtagHashtagCRISPRQCHashtagHashtagGenome EditingHashtagHashtagInDel AnalysisHashtagHashtagPIPPRHashtagHashtagQuality Control Genome EditingHashtagHashtagSafety